Anti-Mullerian Hormone

"Anti-Mullerian Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A glycoprotein that causes regression of MULLERIAN DUCTS. It is produced by SERTOLI CELLS of the TESTES. In the absence of this hormone, the Mullerian ducts develop into structures of the female reproductive tract. In males, defects of this hormone result in persistent Mullerian duct, a form of MALE PSEUDOHERMAPHRODITISM.

Descriptor ID	D054304
MeSH Number(s)	D06.472.334.984.500
Concept/Terms	Anti-Mullerian Hormone Anti-Mullerian Hormone Anti Mullerian Hormone Antimullerian Hormone Mullerian Inhibiting Hormone Mullerian Inhibiting Substance Mullerian-Inhibitory Substance Mullerian Inhibitory Substance Mullerian-Inhibiting Factor Mullerian Inhibiting Factor Mullerian-Inhibiting Hormone Anti-Mullerian Factor Anti Mullerian Factor Mullerian Regression Factor

Below are MeSH descriptors whose meaning is more general than "Anti-Mullerian Hormone".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Gonadal Hormones [D06.472.334]
Testicular Hormones [D06.472.334.984]
Anti-Mullerian Hormone [D06.472.334.984.500]

Below are MeSH descriptors whose meaning is related to "Anti-Mullerian Hormone".

Below are MeSH descriptors whose meaning is more specific than "Anti-Mullerian Hormone".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Mullerian Hormone" by people in this website by year, and whether "Anti-Mullerian Hormone" was a major or minor topic of these publications.

Bar chart showing 19 publications over 12 distinct years, with a maximum of 3 publications in 2018 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2001	0	1	1
2003	0	1	1
2008	1	0	1
2011	1	0	1
2013	0	1	1
2015	2	0	2
2016	1	1	2
2018	1	2	3
2020	2	1	3
2021	1	1	2
2022	1	0	1

Below are the most recent publications written about "Anti-Mullerian Hormone" by people in Profiles.

Butt MS, Saleem J, Aiman S, Zakar R, Sadique I, Fischer F. Serum anti-M?llerian hormone as a predictor of polycystic ovarian syndrome among women of reproductive age. BMC Womens Health. 2022 05 28; 22(1):199.

View in: PubMed
Baker VL, Glassner MJ, Doody K, Schnell VL, Gracia C, Shin SS, Behera MA, Le Saint CM, Alper MM, Pavone ME, Zbella EA, Coddington CC, Marshall LA, Feinberg RF, Cooper AR, Straseski JA, Broyles DL. Validation study of the Access antim?llerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2021 08; 116(2):575-582.

View in: PubMed
Sharara FI, Lelea LL, Rahman S, Klebanoff JS, Moawad GN. A narrative review of platelet-rich plasma (PRP) in reproductive medicine. J Assist Reprod Genet. 2021 May; 38(5):1003-1012.

View in: PubMed
Eubanks AA, Nobles CJ, Hill MJ, DeCherney AH, Kim K, Sjaarda LA, Perkins NJ, Ye A, Zolton JR, Silver RM, Schisterman EF, Mumford SL. Recalled maternal lifestyle behaviors associated with anti-m?llerian hormone of adult female offspring. Reprod Toxicol. 2020 12; 98:75-81.

View in: PubMed
Pecker LH, Hussain S, Christianson MS, Lanzkron S. Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide. Br J Haematol. 2020 12; 191(5):880-887.

View in: PubMed
Tiegs AW, Sun L, Scott RT, Goodman LR. Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve. Fertil Steril. 2020 04; 113(4):788-796.e4.

View in: PubMed
Morin SJ, Tao X, Marin D, Zhan Y, Landis J, Bedard J, Scott RT, Seli E. DNA methylation-based age prediction and telomere length in white blood cells and cumulus cells of infertile women with normal or poor response to ovarian stimulation. Aging (Albany NY). 2018 12 08; 10(12):3761-3773.

View in: PubMed
Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, Shin SS, Marshall LA, Alper MM, Morales AJ, Pavone ME, Behera MA, Zbella EA, Shapiro BS, Straseski JA, Broyles DL. Multicenter evaluation of the Access AMH antim?llerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril. 2018 08; 110(3):506-513.e3.

View in: PubMed
Zolton JR, Parikh TP, Hickstein DD, Holland SM, Hill MJ, DeCherney AH, Wolff EF. Oocyte cryopreservation for women with GATA2 deficiency. J Assist Reprod Genet. 2018 Jul; 35(7):1201-1207.

View in: PubMed
Mumford SL, Legro RS, Diamond MP, Coutifaris C, Steiner AZ, Schlaff WD, Alvero R, Christman GM, Casson PR, Huang H, Santoro N, Eisenberg E, Zhang H, Cedars MI. Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2016 09; 101(9):3288-96.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement